MedPath

Prospective Database of Gastrointestinal Stromal Cell Tumors (GISTs)

Completed
Conditions
Gastrointestinal Stromal Cell Tumors
Foregut Subepithelial Lesions
Registration Number
NCT02147145
Lead Sponsor
Washington University School of Medicine
Brief Summary

Specific Aim 1: To determine patient compliance with a GIST surveillance program Hypothesis: Patient compliance with a GIST surveillance program will be low.

Specific Aim 2: To determine if EUS features of GIST, particularly maximum size, change significantly during a surveillance program.

Hypothesis: EUS features of GIST, particularly maximum size, will not change significantly during a surveillance program.

Specific Aim 3: To determine if EGD measures of GIST size correlate well with EUS measures of GIST size.

Hypothesis: EGD measures of GIST size will correlate well with EUS measured of GIST size.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
187
Inclusion Criteria
  • presenting for EUS with an indication for a SEL in the stomach or esophagus
  • at least 18 years of age
  • able to provide informed consent
Read More
Exclusion Criteria
  • no subepithelial lesion in the stomach or esophagus'
  • less than 18 years of age
  • unable to provide informed consent
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determine the natural history of small (< 30 mm) SELs discovered evaluated by EUS.3 years
Secondary Outcome Measures
NameTimeMethod
Determine the degree of patient compliance with surveillance recommendations.3 years
Describe the diagnostic yield of EUS±FNA in evaluating SELs.2 weeks
Compare SEL size estimation based on EUS, EGD and computer tomography (CT).1 day

Trial Locations

Locations (1)

Northwestern University

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath